F. de Vries

First name
F.
Last name
de Vries
Goossens, M. E., Buntinx, F., Zeegers, M. P., Driessen, J. H., De Bruin, M. L., & de Vries, F. (2015). Influence of metformin intake on the risk of bladder cancer in type 2 diabetes patients. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.12740
Nielen, J. T., van den Bemt, B. J., Boonen, A., Dagnelie, P. C., Emans, P. J., Veldhorst, N., et al. (2015). Identification of antithrombotic drugs related to total joint replacement using anonymised free-text notes: a search strategy in the Clinical Practice Research Datalink. BMJ Open. http://doi.org/10.1136/bmjopen-2015-009017
Wijnands, J. M., van Durme, C. M., Driessen, J. H., Boonen, A., Klop, C., Leufkens, B., et al. (2015). Individuals With Type 2 Diabetes Mellitus Are at an Increased Risk of Gout But This Is Not Due to Diabetes: A Population-Based Cohort Study. Medicine (Baltimore). http://doi.org/10.1097/md.0000000000001358
Stolwijk, C., Essers, I., van Tubergen, A., Boonen, A., Bazelier, M. T., De Bruin, M. L., & de Vries, F. (2015). The epidemiology of extra-articular manifestations in ankylosing spondylitis: a population-based matched cohort study. Ann Rheum Dis. http://doi.org/10.1136/annrheumdis-2014-205253
Driessen, J. H., Henry, R. M., van Onzenoort, H. A., Lalmohamed, A., Burden, A. M., Prieto-Alhambra, D., et al. (2015). Bone fracture risk is not associated with the use of glucagon-like peptide-1 receptor agonists: a population-based cohort analysis. Calcif Tissue Int. http://doi.org/10.1007/s00223-015-9993-5
Klop, C., Gibson-Smith, D., Elders, P. J., Welsing, P. M., Leufkens, H. G., Harvey, N. C., et al. (2015). Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010. Osteoporos Int. http://doi.org/10.1007/s00198-015-3098-x
Knapen, L. M., van Dalem, J., Keulemans, Y. C., van Erp, N. P., Bazelier, M. T., De Bruin, M. L., et al. (2016). Use of incretin agents and risk of pancreatic cancer: a population-based cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.12605
Nielen, J. T., de Vries, F., Dagnelie, P. C., van den Bemt, B. J., Emans, P. J., Lalmohamed, A., et al. (2016). Use of thiazolidinediones and the risk of elective hip or knee replacement: a population based case-control study. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.12786
Bours, S., de Vries, F., van den Bergh, J. P. W., Lalmohamed, A., van Staa, T. P., Leufkens, H. G. M., et al. (2016). Risk of vertebral and non-vertebral fractures in patients with sarcoidosis: a population-based cohort. Osteoporos Int. http://doi.org/10.1007/s00198-015-3426-1
Nielen, J. T., Dagnelie, P. C., Emans, P. J., Veldhorst-Janssen, N., Lalmohamed, A., van Staa, T. P., et al. (2016). Safety and efficacy of new oral anticoagulants and low-molecular-weight heparins compared with aspirin in patients undergoing total knee and hip replacements. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4089